Pharmaceutical Sciences
Research Agricultural
Total number of Record(s): 123
| शीर्षक | मुख्य जाँचकर्ता | शुरुवाती साल | निधीयन एजेंसी | ध्यानाकर्षण क्षेत्र |
|---|---|---|---|---|
| Preclinical Efficacy Validation In Non-Human Primate Stroke Model Of Anti-Thrombin-Clot Specific Streptokinase (ACSSK), With Dual Properties Of Fibrin Specific Clot Dissolution And Prevention Of Arterial Re-Occlusion, For The Treatment Of Acute Myocardial Infarction And Ischemic Stroke | Dr Yogendra Padwad, Scientist, CSIR-Institute of Himalayan Bioresource Technology (CSIR-IHBT), Palampur | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Pre-clinical validation on non-human primates for heart diseases |
| Preclinical studies and process development for production of Tridecaptin M, an antibiotic against colistin resistant Gram negative bacterial infections | Dr Hemraj Nandanwar, ScientistI, CSIR-Institute of Microbial Technology (CSIR-IMTECH), Chandigarh | 2020 | Council of Scientific and Industrial Research (CSIR), Government of India | Genetic engineering to treat gram negative bacterial infections |
| Preparation and Characterization of Novel Formulations of Nepafenac for the Management of Ocular Inflammation. | Mrs. Deepshikha, University Institute Of Pharmaceutical Sciences, Panjab University, Chandigarh (160014) | 2024 | Department of Science and Technology (DST) | Health, Nepafenac for Ocular Inflammation |
| Preparation of Disease management Manual for Primary Health Centers (PHCs) and Hospitals | Prof Satadal Saha, Indian Institute of Technology (IIT) Kharagpur, Prof Dipankar Bandyopadhyay, Indian Institute of Technology (IIT) Guwahati | 2020 | Management of Primary Health Centres | |
| Rational Design of Broad-Spectrum Antiviral Peptides Targeting SARS-CoV2-Spike Protein | Dr Soumendra Rana, Assistant Professor, Indian Institute of Technology (IIT) Bhubaneswar | 2020 | Drug repurposing for COVID-19 | |
| Re-purposing of FDA drugs and exploitation of ancient Ayurvedic knowledge to discover novel inhibitors to block coronavirus propagation | Dr Vishal Trived, Associate Professor, Indian Institute of Technology (IIT) Guwahati | 2020 | Drug repurposing for COVID-19 | |
| Role of sigma-1 receptor in chronic kidney disease | Dr. Madhu CL, Scientist, Indian Veterinary Research Institute (IVRI), Bareilly | 2017 | Department of Science & Technology (DST), New Delhi | Pharmacology; Toxicology |
| Role of sigma-1 receptor in chronic kidney disease | Dr. Madhu CL, Scientist, Indian Veterinary Research Institute (IVRI), Bareilly | 2017 | Department of Science & Technology (DST), New Delhi | Chronic kidney disease |
| Screening lead molecules identified by structure-based rational drug design methods against cytochrome b5 reductase 3 and dopamine beta hydroxylase in spontaneously hypertensive rat models for antihypertensive effects | Prof. Suman Kundu, Professor, South Campus, Delhi University (DU), New Delhi, Prof. C C Kartha, Professor, Rajiv Gandhi Centre for Biotechnology (RGCB), Thiruvananthapuram | 2017 | Department of Biotechnology (DBT), Government of Inida | Rational drug designing for hypertensive rat models |
| Screening of miRNA/long-non coding RNAs as potential prognostic/diagnostic biomarker for Hepatitis E | Dr. Subrat Kumar Panda, Professor, All India Institute of Medical Sciences (AIIMS), New Delhi | 2016 | Department of Biotechnology (DBT), Government of Inida | Biomarker of Hepatitis E |